These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24464687)

  • 1. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial.
    Toma M; Ezekowitz JA; Bakal JA; O'Connor CM; Hernandez AF; Sardar MR; Zolty R; Massie BM; Swedberg K; Armstrong PW; Starling RC
    Eur J Heart Fail; 2014 Mar; 16(3):334-41. PubMed ID: 24464687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute heart failure: perspectives from a randomized trial and a simultaneous registry.
    Ezekowitz JA; Hu J; Delgado D; Hernandez AF; Kaul P; Leader R; Proulx G; Virani S; White M; Zieroth S; O'Connor C; Westerhout CM; Armstrong PW
    Circ Heart Fail; 2012 Nov; 5(6):735-41. PubMed ID: 23032196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
    JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
    Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA
    J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort.
    Yeh JK; Hsiao YC; Jian CR; Wang CH; Wen MS; Kuo CT; Tsai FC; Wu VC; Chen TH
    PLoS One; 2016; 11(1):e0145514. PubMed ID: 26752417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
    Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
    Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
    J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent effect of left ventricular ejection fraction on long-term mortality in patients with heart failure (from the Heart Failure Survey in ISrael).
    Koifman E; Kopel E; Medvedovsky D; Maor E; Hamdan A; Goldenberg I; Klempfner R
    Am J Cardiol; 2013 Dec; 112(12):1901-6. PubMed ID: 24063837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality.
    Goto T; Wakami K; Fukuta H; Fujita H; Tani T; Ohte N
    Heart Vessels; 2016 May; 31(5):734-43. PubMed ID: 25771802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure.
    Blumer V; Mentz RJ; Sun JL; Butler J; Metra M; Voors AA; Hernandez AF; O'Connor CM; Greene SJ
    Circ Heart Fail; 2021 Apr; 14(4):e007871. PubMed ID: 33775110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
    Solomon SD; Anavekar N; Skali H; McMurray JJ; Swedberg K; Yusuf S; Granger CB; Michelson EL; Wang D; Pocock S; Pfeffer MA;
    Circulation; 2005 Dec; 112(24):3738-44. PubMed ID: 16330684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.
    Kaul P; Reed SD; Hernandez AF; Howlett JG; Ezekowitz JA; Li Y; Zheng Y; Rouleau JL; Starling RC; O'Connor CM; Califf RM; Armstrong PW
    JACC Heart Fail; 2013 Dec; 1(6):523-30. PubMed ID: 24622005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
    Böhm M; Perez AC; Jhund PS; Reil JC; Komajda M; Zile MR; McKelvie RS; Anand IS; Massie BM; Carson PE; McMurray JJ;
    Eur J Heart Fail; 2014 Jul; 16(7):778-87. PubMed ID: 24864045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.